NCT06086093 is a NA clinical trial of RespireAid TM/placebo in Respiration Disorders, sponsored by Sun Ten Pharmaceutical Co., Ltd..

Who is sponsoring NCT06086093?

NCT06086093 is sponsored by Sun Ten Pharmaceutical Co., Ltd..

What drugs are being tested in NCT06086093?

Interventions in NCT06086093: RespireAid TM/placebo.

What condition does NCT06086093 study?

NCT06086093 studies Respiration Disorders.

Is NCT06086093 still recruiting?

NCT06086093 is currently completed. Last updated 22 December 2023.

Last reviewed 2023-12-22 · How we verify

NCT06086093

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Efficacy of RespireAidTM in Patient With Externally Contracted Seasonal Epidemic (外感時疫)

Completed NA Last updated 22 December 2023

What this trial tests

NA trial testing RespireAid TM/placebo in Respiration Disorders in 260 participants. Completed in 15 December 2023.

Timeline

7 August 2023

Primary endpoint
11 October 2023

15 December 2023

Quick facts

Lead sponsor	Sun Ten Pharmaceutical Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	260
Start date	7 August 2023
Primary completion	11 October 2023
Estimated completion	15 December 2023
Sites	2 locations across Taiwan

Drugs / interventions tested

RespireAid TM/placebo

Conditions studied

Respiration Disorders — all drugs for Respiration Disorders →

Sponsor

Sun Ten Pharmaceutical Co., Ltd.

Who can join

Adults 18 to 79, any sex, with Respiration Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about in the main objective of this study is to evaluate the clinical efficacy of the RespireAidTM (Tai-wan-Qing-Guan-Yi-Hao) to ease the symptoms of fever, sore throat, and cough, and the safety after treatment. Participants will Take 1 sachet(5g) 4 times daily. There is a comparison group: Researchers will compare placebo to see if RespireAidTM.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiration Disorders

Currently open trials in the same condition.

NCT06271213 — The Gut-Lung Axis and Respiratory Illness in Children · recruiting
NCT06019949 — Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury · NA · recruiting
NCT03709199 — Long Term Follow up of Children Enrolled in the REDvent Study · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06086093 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Ten Pharmaceutical Co., Ltd.
Last refreshed: 22 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06086093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing